![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.374, 2002-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Procainamide, propafenone and amiodarone all useful in AF
Inpharma, Vol. 1, Iss. 1601, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Amiodarone more effective but propafenone safer in recurrent AF
Inpharma, Vol. 1, Iss. 1430, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Amiodarone, sotalol equivalent in atrial fibrillation
Inpharma, Vol. 1, Iss. 1487, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Propafenone/sotalol: Cardiogenic shock: case report
Reactions Weekly, Vol. 1, Iss. 1292, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
QOL impairment in AF not remedied by treatment
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 447, 2004-01 ,pp. :